DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Omaxe Limited — Outcome of Board Meeting

NSE 2 hrs ago·12 Aug 2026, 10:57 am

Omaxe

Omaxe Limited has announced the release of its un-audited financial results for the quarter ending June 30, 2026. The company has submitted these reports to the stock exchange, providing an update on its standalone and consolidated performance for the period.

For investors, this announcement is a key milestone as it offers a fresh look at the company's operational health. The un-audited figures allow stakeholders to track the company's progress against its previous performance and market expectations.

Investors should focus on the details within the report, particularly the revenue growth, net profit margins, and the company's debt position. Monitoring these metrics will help in assessing the company's current trajectory and future potential.